Trademark: 79191983
Status Date
Tuesday, April 4, 2017
Filing Date
Thursday, June 2, 2016
Published for Opposition
Tuesday, February 14, 2017
Abandoned Date
Tuesday, April 4, 2017
5 Pharmaceutical preparations for the treatment of cancer and auto-immune diseases
Color is not claimed as a feature of the mark.
The wording "TEG" has no meaning in a foreign language.
Feb 26, 2018
Correction From The Ib Examined, No Action Is Needed
Feb 2, 2018
Correction Transaction Received From Ib
Apr 22, 2017
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Apr 21, 2017
Death Of International Registration
Mar 3, 2017
Extension Of Time To Oppose Received
Feb 14, 2017
Published For Opposition
Feb 11, 2017
Notification Processed By Ib
Jan 25, 2017
Notification Of Possible Opposition Sent To Ib
Jan 25, 2017
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Jan 25, 2017
Notice Of Publication
Jan 9, 2017
Law Office Publication Review Completed
Dec 19, 2016
Approved For Pub - Principal Register
Dec 1, 2016
Teas/Email Correspondence Entered
Dec 1, 2016
Correspondence Received In Law Office
Nov 22, 2016
Assigned To Lie
Nov 11, 2016
Refusal Processed By Ib
Nov 3, 2016
Teas Response To Office Action Received
Nov 3, 2016
Teas Response To Office Action Received
Oct 21, 2016
Non-Final Action Mailed - Refusal Sent To Ib
Oct 21, 2016
Refusal Processed By Mpu
Oct 5, 2016
Non-Final Action (Ib Refusal) Prepared For Review
Oct 4, 2016
Non-Final Action Written
Oct 1, 2016
Application Filing Receipt Mailed
Sep 27, 2016
Assigned To Examiner
Sep 27, 2016
New Application Office Supplied Data Entered In Tram
Sep 26, 2016
Limitation From Original Application Entered
Sep 22, 2016
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
